Digital Therapeutics (DTx) Market Worth $21.9 Billion | MarketsandMarkets™
The sales channel segment in the digital therapeutics market is categorized into business-to-business (B2B) and business-to-customer (B2C).
- The sales channel segment in the digital therapeutics market is categorized into business-to-business (B2B) and business-to-customer (B2C).
- Digital Therapeutics (DTx) Market Dynamics:
Key Market Players of Digital Therapeutics (DTx) Industry:
Prominent players in the digital therapeutics market include Noom, Inc (US), Teladoc Health, Inc. (US), Omada Health, Inc. (US), WellDoc, Inc (US), Biofourmis (US), Better Therapeutics, Inc (US), Amalgm Rx (US), CogniFit Inc (US), Headspace Health (US), Propeller Health (US), Virta Health Corp (US), 2Morrow, Inc. (US), Realizedcare (US), Canary Health (US), Twill Inc. (US), Click Therapeutics, Inc. (US), Akili, Inc. (US), Cognoa, Inc (US), Wellthy Therapeutics Pvt. - Market Development: Comprehensive information detailing lucrative market – the report analyses the digital therapeutics market across various regions as well as countries.
- Market Diversification: Exhaustive information about new software and programs, untapped geographies, recent developments, and investments in the digital therapeutics market.